Logo image of ZETA

ZETA GLOBAL HOLDINGS CORP-A (ZETA) Stock Fundamental Analysis

NYSE:ZETA - New York Stock Exchange, Inc. - US98956A1051 - Common Stock - Currency: USD

13.68  +0.19 (+1.41%)

After market: 13.58 -0.1 (-0.73%)

Fundamental Rating

5

ZETA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. While ZETA has a great health rating, there are worries on its profitability. ZETA is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ZETA had positive earnings in the past year.
In the past year ZETA had a positive cash flow from operations.
ZETA had negative earnings in each of the past 5 years.
In the past 5 years ZETA always reported a positive cash flow from operatings.
ZETA Yearly Net Income VS EBIT VS OCF VS FCFZETA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

ZETA has a Return On Assets of -6.28%. This is comparable to the rest of the industry: ZETA outperforms 44.33% of its industry peers.
ZETA has a Return On Equity (-10.31%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.28%
ROE -10.31%
ROIC N/A
ROA(3y)-33.39%
ROA(5y)-38.04%
ROE(3y)-110.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZETA Yearly ROA, ROE, ROICZETA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

The Gross Margin of ZETA (60.27%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ZETA has remained more or less at the same level.
ZETA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y-1.17%
ZETA Yearly Profit, Operating, Gross MarginsZETA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

7

2. Health

2.1 Basic Checks

ZETA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZETA has more shares outstanding
ZETA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ZETA has been reduced compared to a year ago.
ZETA Yearly Shares OutstandingZETA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
ZETA Yearly Total Debt VS Total AssetsZETA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ZETA has an Altman-Z score of 4.37. This indicates that ZETA is financially healthy and has little risk of bankruptcy at the moment.
ZETA has a Altman-Z score of 4.37. This is in the better half of the industry: ZETA outperforms 68.44% of its industry peers.
The Debt to FCF ratio of ZETA is 2.13, which is a good value as it means it would take ZETA, 2.13 years of fcf income to pay off all of its debts.
ZETA has a better Debt to FCF ratio (2.13) than 66.67% of its industry peers.
ZETA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
ZETA has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.13
Altman-Z 4.37
ROIC/WACCN/A
WACC10.45%
ZETA Yearly LT Debt VS Equity VS FCFZETA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

ZETA has a Current Ratio of 3.09. This indicates that ZETA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ZETA (3.09) is better than 74.82% of its industry peers.
ZETA has a Quick Ratio of 3.09. This indicates that ZETA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.09, ZETA is in the better half of the industry, outperforming 75.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 3.09
ZETA Yearly Current Assets VS Current LiabilitesZETA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.97% over the past year.
Looking at the last year, ZETA shows a very strong growth in Revenue. The Revenue has grown by 38.02%.
The Revenue has been growing by 26.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)72.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)38.02%
Revenue growth 3Y29.95%
Revenue growth 5Y26.86%
Sales Q2Q%35.64%

3.2 Future

The Earnings Per Share is expected to grow by 26.72% on average over the next years. This is a very strong growth
ZETA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.07% yearly.
EPS Next Y20.9%
EPS Next 2Y23.14%
EPS Next 3Y25.72%
EPS Next 5Y26.72%
Revenue Next Year25.12%
Revenue Next 2Y21.76%
Revenue Next 3Y20.98%
Revenue Next 5Y17.07%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ZETA Yearly Revenue VS EstimatesZETA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
ZETA Yearly EPS VS EstimatesZETA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ZETA is valuated rather expensively with a Price/Earnings ratio of 21.38.
Based on the Price/Earnings ratio, ZETA is valued a bit cheaper than the industry average as 75.18% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.22. ZETA is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 14.10 indicates a correct valuation of ZETA.
Based on the Price/Forward Earnings ratio, ZETA is valued cheaper than 85.82% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.86. ZETA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.38
Fwd PE 14.1
ZETA Price Earnings VS Forward Price EarningsZETA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ZETA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ZETA is cheaper than 71.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.31
EV/EBITDA N/A
ZETA Per share dataZETA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ZETA's earnings are expected to grow with 25.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.02
PEG (5Y)N/A
EPS Next 2Y23.14%
EPS Next 3Y25.72%

More info and screens

0

5. Dividend

5.1 Amount

ZETA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZETA GLOBAL HOLDINGS CORP-A

NYSE:ZETA (5/2/2025, 8:04:00 PM)

After market: 13.58 -0.1 (-0.73%)

13.68

+0.19 (+1.41%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)N/A N/A
Inst Owners66.26%
Inst Owner Change2.32%
Ins Owners8.73%
Ins Owner Change0.05%
Market Cap3.25B
Analysts81
Price Target31.93 (133.41%)
Short Float %10.93%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.18%
Min EPS beat(2)8.93%
Max EPS beat(2)9.43%
EPS beat(4)3
Avg EPS beat(4)7.97%
Min EPS beat(4)-8.62%
Max EPS beat(4)22.13%
EPS beat(8)5
Avg EPS beat(8)4.42%
EPS beat(12)7
Avg EPS beat(12)76.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.24%
Min Revenue beat(2)4.18%
Max Revenue beat(2)4.3%
Revenue beat(4)4
Avg Revenue beat(4)3.94%
Min Revenue beat(4)2.15%
Max Revenue beat(4)5.15%
Revenue beat(8)7
Avg Revenue beat(8)3.21%
Revenue beat(12)11
Avg Revenue beat(12)3.78%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.96%
PT rev (3m)-16.19%
EPS NQ rev (1m)-1.97%
EPS NQ rev (3m)-5.39%
EPS NY rev (1m)-0.35%
EPS NY rev (3m)-3.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.74%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)1.94%
Valuation
Industry RankSector Rank
PE 21.38
Fwd PE 14.1
P/S 3.23
P/FCF 35.31
P/OCF 24.29
P/B 4.8
P/tB 15.73
EV/EBITDA N/A
EPS(TTM)0.64
EY4.68%
EPS(NY)0.97
Fwd EY7.09%
FCF(TTM)0.39
FCFY2.83%
OCF(TTM)0.56
OCFY4.12%
SpS4.23
BVpS2.85
TBVpS0.87
PEG (NY)1.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.28%
ROE -10.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.27%
FCFM 9.16%
ROA(3y)-33.39%
ROA(5y)-38.04%
ROE(3y)-110.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y-1.17%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.13
Debt/EBITDA N/A
Cap/Depr 74.45%
Cap/Sales 4.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 3.09
Altman-Z 4.37
F-Score5
WACC10.45%
ROIC/WACCN/A
Cap/Depr(3y)79.39%
Cap/Depr(5y)80.62%
Cap/Sales(3y)5.76%
Cap/Sales(5y)6.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y20.9%
EPS Next 2Y23.14%
EPS Next 3Y25.72%
EPS Next 5Y26.72%
Revenue 1Y (TTM)38.02%
Revenue growth 3Y29.95%
Revenue growth 5Y26.86%
Sales Q2Q%35.64%
Revenue Next Year25.12%
Revenue Next 2Y21.76%
Revenue Next 3Y20.98%
Revenue Next 5Y17.07%
EBIT growth 1Y63.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year90.23%
EBIT Next 3Y44.72%
EBIT Next 5Y33.72%
FCF growth 1Y68.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.88%
OCF growth 3Y44.58%
OCF growth 5Y34.33%